oxybutynin

Action and Spectrum

Drug Interaction

Adverse Reaction

Adverse drug reactions:   

Frequency Defined  

>10%  

Dry mouth   

Somnolence   

Nausea  

Constipation   

1-10%  

Dry eyes   

Diarrhea  

Asthenia  

Dizziness   

Headache   

Pain   

Rhinitis  

Blurred vision  

Nausea  

<1%  

Dysphagia  

Frequent bowel movements  

Chest discomfort  

Thirst  

Anorexia  

Fluid retention  

Hot flush  

Dysphonia  

Frequency Not Defined  

Cycloplegia  

Memory impairment  

Mydriasis  

Tachycardia  

Impairment of mental alertness  

Black Box Warning

Contraindication / Caution

Pregnancy / Lactation

Pregnancy warnings:     

Pregnancy category: N/A 

Breastfeeding warnings:  

The release of the drug into the human breastmilk is unknown 

Pregnancy Categories:      

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.      

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      

Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits      

Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.      

Category N: There is no data available for the drug under this category

Pharmacology

Adminstartion

Patient Information Leaflet

Patient Information Leaflet  

Generic Name: oxybutynin 

Pronunciation: OX-i-BUE-ti-nin 

Why do we use oxybutynin? 

oxybutynin belongs to the class of anticholinergic agents used to treat muscle spasms of the bladder, overactive bladder, and Detrusor Overactivity in pediatrics